Psyched: Psychedelic Therapy In The Workplace, UCL’s Brain Imaging Study, COMPASS Trials And More
Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
Mental health care company COMPASS Pathways plc (NASDAQ: CMPS) has announced positive data demonstrating the potential of its proprietary synthetic psilocybin compound COMP360 in treating depression within Type II bipolar disorder.
Psychedelic Stock Gainers And Losers From December 9, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.78% at $1.11 Numinus Wellness (OTC:NUMIF) shares closed up 1.88% at…
Colorado’s Psychedelics Legal Scenario: Insurance & State Aid, Advisory Board And Local Regulations
Part three of three-part series.
See previous stories:
Colorado's New Psychedelics Regulations: Co-Author Of The Bill Replies To Concerns
Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments
(Part four of a four-part series)
See previous stories:
Chefs’ Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session.
‘Congress Pushes Military To Consider Psychedelics And Marijuana Therapy, While Other Cannabis Provisions Left Out Of Defense Bill’ – MarijuanaMoment
https://www.marijuanamoment.net/congress-pushes-militar
‘DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn: “DEA is committed to ensuring an adequate and uninterrupted supply of controlled substances.”‘ – Marijuana Moment
https://www.marijuanamoment.net/dea-proposes-even-higher-2023-production-quotas-for-psychedelics-like-mdma-and-psilocyn/
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon
Psychedelic Stock Gainers And Losers From November 23, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 54.13% at $0.13 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 8.56%…